Insights into MMP-TIMP interactions

Bode W, Fernandez-Catalan C, Grams F, Gomis-Ruth FX, Nagase H, Tschesche H, Maskos K (1999)
In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. Annals of the New York Academy of Sciences, 878. NEW YORK ACAD SCIENCES: 73-91.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Konferenzbeitrag | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Abstract / Bemerkung
The proteolytic activity of the matrix metalloproteinases (MMPs) involved in extracellular matrix degradation must be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance can result in serious diseases such as arthritis and tumor growth and metastasis, Knowledge of the tertiary structures of the proteins involved in such processes is crucial for understanding their functional properties and to interfere with associated dysfunctions, Within the last few years, several three-dimensional structures have been determined showing the domain organization, the polypeptide fold, and the main specificity determinants of the MMPs. Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs, Very recently, structural information also became available for some TIMP structures and MMP-TIMP complexes, and these new data elucidated important structural features that govern the enzyme-inhibitor interaction.
Erscheinungsjahr
Titel des Konferenzbandes
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS
Band
878
Seite
73-91
ISSN
PUB-ID

Zitieren

Bode W, Fernandez-Catalan C, Grams F, et al. Insights into MMP-TIMP interactions. In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. Annals of the New York Academy of Sciences. Vol 878. NEW YORK ACAD SCIENCES; 1999: 73-91.
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F. X., Nagase, H., Tschesche, H., & Maskos, K. (1999). Insights into MMP-TIMP interactions. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, Annals of the New York Academy of Sciences, 878, 73-91. NEW YORK ACAD SCIENCES. doi:10.1111/j.1749-6632.1999.tb07675.x
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F. X., Nagase, H., Tschesche, H., and Maskos, K. (1999). “Insights into MMP-TIMP interactions” in INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS Annals of the New York Academy of Sciences, vol. 878, (NEW YORK ACAD SCIENCES), 73-91.
Bode, W., et al., 1999. Insights into MMP-TIMP interactions. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. Annals of the New York Academy of Sciences. no.878 NEW YORK ACAD SCIENCES, pp. 73-91.
W. Bode, et al., “Insights into MMP-TIMP interactions”, INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, Annals of the New York Academy of Sciences, vol. 878, NEW YORK ACAD SCIENCES, 1999, pp.73-91.
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F.X., Nagase, H., Tschesche, H., Maskos, K.: Insights into MMP-TIMP interactions. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. Annals of the New York Academy of Sciences. 878, p. 73-91. NEW YORK ACAD SCIENCES (1999).
Bode, W, Fernandez-Catalan, C, Grams, F, Gomis-Ruth, FX, Nagase, H, Tschesche, Harald, and Maskos, K. “Insights into MMP-TIMP interactions”. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. NEW YORK ACAD SCIENCES, 1999.Vol. 878. Annals of the New York Academy of Sciences. 73-91.

72 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Cartilage breakdown in rheumatoid arthritis.
Rannou F, François M, Corvol MT, Berenbaum F., Joint Bone Spine 73(1), 2006
PMID: 16087381
Chlorhexidine arrests subclinical degradation of dentin hybrid layers in vivo.
Hebling J, Pashley DH, Tjäderhane L, Tay FR., J Dent Res 84(8), 2005
PMID: 16040733
Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities.
Djafarzadeh R, Mojaat A, Vicente AB, von Lüttichau I, Nelson PJ., Biol Chem 385(7), 2004
PMID: 15318815
Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, Béliveau R., Transpl Int 16(4), 2003
PMID: 12730807
A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Marini S, Fasciglione GF, Monteleone G, Maiotti M, Tarantino U, Coletta M., Clin Biochem 36(4), 2003
PMID: 12810159
Role of tissue inhibitor of metalloproteases-1 in junction dynamics in the testis.
Mruk DD, Siu MK, Conway AM, Lee NP, Lau AS, Cheng CY., J Androl 24(4), 2003
PMID: 12826691
Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia.
Wagner S, Nagel S, Kluge B, Schwab S, Heiland S, Koziol J, Gardner H, Hacke W., Brain Res 984(1-2), 2003
PMID: 12932840
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.
Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, Ghorpade A., Glia 44(1), 2003
PMID: 12951656
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S., Kidney Int 62(6), 2002
PMID: 12427154
Role of muscle endopeptidases and their inhibitors in meat tenderness.
Sentandreu MA, Coulis G, Ouali A., Trends in food science & technology. 13(12), 2002
PMID: IND43619894
Enhancement of scleral macromolecular permeability with prostaglandins.
Weinreb RN., Trans Am Ophthalmol Soc 99(), 2001
PMID: 11797317
Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.
Gusman H, Travis J, Helmerhorst EJ, Potempa J, Troxler RF, Oppenheim FG., Infect Immun 69(3), 2001
PMID: 11179305
Phenotypic alterations in Caki-1 cells as a consequence of TIMP-1 overexpression.
Reid HM, McElligott AM, McGlynn H., Cancer Lett 169(2), 2001
PMID: 11431108
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice.
Schett G, Hayer S, Tohidast-Akrad M, Schmid BJ, Lang S, Türk B, Kainberger F, Haralambous S, Kollias G, Newby AC, Xu Q, Steiner G, Smolen J., Arthritis Rheum 44(12), 2001
PMID: 11762950

71 References

Daten bereitgestellt von Europe PubMed Central.

Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE., Structure 3(6), 1995
PMID: 8590015
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ., Nat. Struct. Biol. 1(2), 1994
PMID: 7656013
The NMR structure of the inhibited catalytic domain of human stromelysin-1.
Gooley PR, O'Connell JF, Marcy AI, Cuca GC, Salowe SP, Bush BL, Hermes JD, Esser CK, Hagmann WK, Springer JP., Nat. Struct. Biol. 1(2), 1994
PMID: 7656014
Structure of human neutrophil collagenase reveals large S1' specificity pocket.
Stams T, Spurlino JC, Smith DL, Wahl RC, Ho TF, Qoronfleh MW, Banks TM, Rubin B., Nat. Struct. Biol. 1(2), 1994
PMID: 7656015
Crystal structure of the haemopexin-like C-terminal domain of gelatinase A.
Libson AM, Gittis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE., Nat. Struct. Biol. 2(11), 1995
PMID: 7583664
Structure of astacin with a transition-state analogue inhibitor.
Grams F, Dive V, Yiotakis A, Yiallouros I, Vassiliou S, Zwilling R, Bode W, Stocker W., Nat. Struct. Biol. 3(8), 1996
PMID: 8756323
Activation of human neutrophil procollagenase by stromelysin 2.
Knauper V, Murphy G, Tschesche H., Eur. J. Biochem. 235(1-2), 1996
PMID: 8631328
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.
Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ., Nature 318(6041), 1985
PMID: 3903517
Structural basis of the action of thermolysin and related zinc peptidases
Matthews, Accounts of Chemical Research 21(9), 1988
The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.
Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJ., Biochemistry 30(33), 1991
PMID: 1868085
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin).
Netzel-Arnett S, Sang QX, Moore WG, Navre M, Birkedal-Hansen H, Van Wart HE., Biochemistry 32(25), 1993
PMID: 8390857
Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T, Zucker S, Cockett MI, Willenbrock F, Tickle S, O'Connell JP, Scothern JM, Murphy G, Docherty AJ., Biochemistry 33(21), 1994
PMID: 7911325
Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself.
Lovejoy B, Hassell AM, Luther MA, Weigl D, Jordan SR., Biochemistry 33(27), 1994
PMID: 8031754
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W., Biochemistry 34(43), 1995
PMID: 7577999
Matrilysin-inhibitor complexes: common themes among metalloproteases.
Browner MF, Smith WW, Castelhano AL., Biochemistry 34(20), 1995
PMID: 7756291
Matrix metalloproteinase inhibitors 1998
Beckett, Expert Opinion on Therapeutic Patents 8(3), 1998
1.56 A structure of mature truncated human fibroblast collagenase.
Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA., Proteins 19(2), 1994
PMID: 8090713
On the size of the active site in proteases. I. Papain.
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
Computational sequence analysis of matrix metalloproteinases.
Sang QA, Douglas DA., J. Protein Chem. 15(2), 1996
PMID: 8924199
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH., Science 263(5145), 1994
PMID: 8278810

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 10415721
PubMed | Europe PMC

Suchen in

Google Scholar